Bitcoin halving
What does that mean?
$2.77T
Total marketcap
$109.19B
Total volume
BTC 49.66%     ETH 15.36%
Dominance

Merck & Co., Inc. MRK.SN Stock

119.99 USD {{ price }} 0.000000% {{change_pct}}%
COUNTRY
Chile
Exchange
Santiago
Market Cap
333.68B USD
LOW - HIGH [24H]
119.99 - 119.99 USD
VOLUME [24H]
0 USD
{{ volume }}
P/E Ratio
857.07
Earnings per share
0.14 USD

Merck & Co., Inc. Price Chart

Merck & Co., Inc. MRK.SN Financial and Trading Overview

Merck & Co., Inc. stock price 119.99 USD
Previous Close 109.8 USD
Open 0 USD
Bid 0 USD x N/A
Ask 0 USD x N/A
Day's Range 111.5 - 111.5 USD
52 Week Range 82.65 - 111.5 USD
Volume 0 USD
Avg. Volume 0 USD
Market Cap 282.92B USD
Beta (5Y Monthly) 0.357746
PE Ratio (TTM) 19.527145
EPS (TTM) 0.14 USD
Forward Dividend & Yield 2.92 (2.66%)
Ex-Dividend Date June 14, 2023
1y Target Est N/A

MRK.SN Valuation Measures

Enterprise Value 299.04B USD
Trailing P/E 19.527145
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.889052
Price/Book (mrq) 6.041068
Enterprise Value/Revenue 5.168
Enterprise Value/EBITDA 13.37

Trading Information

Merck & Co., Inc. Stock Price History

Beta (5Y Monthly) 0.357746
52-Week Change 28.91%
S&P500 52-Week Change 20.43%
52 Week High 111.5 USD
52 Week Low 82.65 USD
50-Day Moving Average 109.8 USD
200-Day Moving Average 103.03 USD

MRK.SN Share Statistics

Avg. Volume (3 month) 0 USD
Avg. Daily Volume (10-Days) 0 USD
Shares Outstanding 2.54B
Float 2.53B
Short Ratio N/A
% Held by Insiders 0.088%
% Held by Institutions 77.43%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 2.8
Trailing Annual Dividend Yield 2.55%
5 Year Average Dividend Yield N/A
Payout Ratio 0.49040002
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 22.51%
Operating Margin (ttm) 32.31%
Gross Margin 72.75%
EBITDA Margin 38.65%

Management Effectiveness

Return on Assets (ttm) 10.89%
Return on Equity (ttm) 29.69%

Income Statement

Revenue (ttm) 57.87B USD
Revenue Per Share (ttm) 22.83 USD
Quarterly Revenue Growth (yoy) -8.90%
Gross Profit (ttm) 42.08B USD
EBITDA 22.37B USD
Net Income Avi to Common (ttm) 13.03B USD
Diluted EPS (ttm) 5.71
Quarterly Earnings Growth (yoy) -34.50%

Balance Sheet

Total Cash (mrq) 10.39B USD
Total Cash Per Share (mrq) 4.09 USD
Total Debt (mrq) 30.75B USD
Total Debt/Equity (mrq) 65.55 USD
Current Ratio (mrq) 1.444
Book Value Per Share (mrq) 18.457

Cash Flow Statement

Operating Cash Flow (ttm) 15.67B USD
Levered Free Cash Flow (ttm) 9.5B USD

Profile of Merck & Co., Inc.

Country Chile
State NJ
City Rahway
Address 126 East Lincoln Avenue
ZIP 07065
Phone 908 740 4000
Website https://www.merck.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 67000

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.

Q&A For Merck & Co., Inc. Stock

What is a current MRK.SN stock price?

Merck & Co., Inc. MRK.SN stock price today per share is 119.99 USD.

How to purchase Merck & Co., Inc. stock?

You can buy MRK.SN shares on the Santiago exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Merck & Co., Inc.?

The stock symbol or ticker of Merck & Co., Inc. is MRK.SN.

Which industry does the Merck & Co., Inc. company belong to?

The Merck & Co., Inc. industry is Drug Manufacturers-General.

How many shares does Merck & Co., Inc. have in circulation?

The max supply of Merck & Co., Inc. shares is 2.78B.

What is Merck & Co., Inc. Price to Earnings Ratio (PE Ratio)?

Merck & Co., Inc. PE Ratio is 857.07140000 now.

What was Merck & Co., Inc. earnings per share over the trailing 12 months (TTM)?

Merck & Co., Inc. EPS is 0.14 USD over the trailing 12 months.

Which sector does the Merck & Co., Inc. company belong to?

The Merck & Co., Inc. sector is Healthcare.